CIK 0001326732 · Accelerated filer
Xencor Inc
Sign in to watch- Ticker
- XNCR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 201622502
- Phone
- 626-305-5900
- Business address
- 465 N. HALSTEAD ST., SUITE 200, PASADENA, CA, 91107
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,591,617
- in 2 filings
Net −$3,591,617. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-03 | Dahiyat Bassil I PRESIDENT & CEO | Option exercise | +8,808 | $15.69 | $138K | 375,390 |
| 2025-02-03 | Dahiyat Bassil I PRESIDENT & CEO | Option exercise · Stock Option (Right to Buy) | −8,808 | 0 | ||
| 2024-12-04 | Montgomery Alan Bruce Director | Option exercise 10b5-1 | +991 | $15.35 | $15K | 10,131 |
| 2024-12-04 | Montgomery Alan Bruce Director | Option exercise 10b5-1 | +430 | $20.00 | $9K | 10,561 |
| 2024-12-04 | Montgomery Alan Bruce Director | Sale 10b5-1 | −1,421 | $27.03 | $38K | 9,140 |
| 2024-12-04 | Montgomery Alan Bruce Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −991 | 5,716 | ||
| 2024-12-04 | Montgomery Alan Bruce Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −430 | 2,062 | ||
| 2024-12-02 | Montgomery Alan Bruce Director | Option exercise 10b5-1 | +8,293 | $15.35 | $127K | 17,433 |
| 2024-12-02 | Montgomery Alan Bruce Director | Option exercise 10b5-1 | +5,008 | $20.00 | $100K | 22,441 |
| 2024-12-02 | Montgomery Alan Bruce Director | Sale 10b5-1 | −13,301 | $27.03 | $360K | 9,140 |
| 2024-12-02 | Montgomery Alan Bruce Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,008 | 2,492 | ||
| 2024-12-02 | Montgomery Alan Bruce Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,293 | 6,707 | ||
| 2024-11-22 | Dahiyat Bassil I PRESIDENT & CEO | Option exercise 10b5-1 | +13,548 | $15.69 | $213K | 366,163 |
| 2024-11-22 | Dahiyat Bassil I PRESIDENT & CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −13,548 | 8,808 | ||
| 2024-11-21 | Dahiyat Bassil I PRESIDENT & CEO | Option exercise 10b5-1 | +49,278 | $15.69 | $773K | 401,893 |
| 2024-11-21 | Dahiyat Bassil I PRESIDENT & CEO | Sale 10b5-1 | −49,278 | $24.07 | $1.2M | 352,615 |
| 2024-11-21 | Dahiyat Bassil I PRESIDENT & CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −49,278 | 22,356 | ||
| 2024-11-13 | Dahiyat Bassil I PRESIDENT & CEO | Option exercise 10b5-1 | +3,366 | $15.69 | $53K | 355,981 |
| 2024-11-13 | Dahiyat Bassil I PRESIDENT & CEO | Sale 10b5-1 | −3,366 | $24.02 | $81K | 352,615 |
| 2024-11-13 | Dahiyat Bassil I PRESIDENT & CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,366 | 71,634 |
Page 6 of 11 · 211 trades